Sacubitril/Valsartan Improves Left Ventricular Ejection Fraction and Reverses Cardiac Remodeling in Taiwanese Patients with Heart Failure and Reduced Ejection Fraction

BACKGROUND: The angiotensin receptor-neprilysin inhibitor sacubitril/valsartan is known to improve outcomes of cardiac death and hospitalization due to heart failure in patients with heart failure and reduced ejection fraction (HFrEF). However, data on improvements in ejection fraction after using s...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Acta Cardiol Sin
Main Authors: Liu, Li-Wei, Wu, Po-Ching, Chiu, Mei-Ya, Tu, Pei-Fen, Fang, Ching-Chang
Formato: Artigo
Idioma:Inglês
Publicado em: Taiwan Society of Cardiology 2020
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7062818/
https://ncbi.nlm.nih.gov/pubmed/32201463
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.6515/ACS.202003_36(2).20190812A
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados